1.
Product Overview
2.
Research Methodology
3.
Voice of Customer
3.1. Factors Driving the Global Genome Editing
Market
3.2. Technology Compatibility
3.3. Unmet Needs and Challenges
4.
Impact of COVID-19
on Global Genome Editing Market
5.
Executive Summary
6.
Global Genome Editing
Market Outlook
6.1. Market Size & Forecast
6.1.1.
By Value
6.2. Market Share & Forecast
6.2.1. By Technique (CRISPR, TALENs, Zinc Finger
Nucleases, Others)
6.2.2. By Application (Cell Line Engineering, Animal
Genetic Engineering, Plant Genetic Engineering, Others)
6.2.3. By Delivery Method (Ex-vivo, In-vivo)
6.2.4. By End User (Pharmaceutical &
Biotechnology Companies, Clinical Research Organization, Research Institutes)
6.2.5. By Company (2023)
6.2.6. By
Region
6.3.
Product Market Map
7.
North America Genome
Editing Market Outlook
7.1. Market Size & Forecast
7.1.1.
By Value
7.2. Market Share & Forecast
7.2.1. By Technique
7.2.2. By Application
7.2.3. By Delivery Method
7.2.4. By End User
7.2.5.
By Country
7.3. North America: Country Analysis
7.3.1.
United States Genome
Editing Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Technique
7.3.1.2.2.
By Application
7.3.1.2.3.
By Delivery Method
7.3.1.2.4.
By End User
7.3.2.
Canada Genome
Editing Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Technique
7.3.2.2.2.
By Application
7.3.2.2.3.
By Delivery Method
7.3.2.2.4.
By End User
7.3.3.
Mexico Genome
Editing Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Technique
7.3.3.2.2.
By Application
7.3.3.2.3.
By Delivery Method
7.3.3.2.4.
By End User
8.
Europe Genome
Editing Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share & Forecast
8.2.1. By Technique
8.2.2. By Application
8.2.3. By Delivery Method
8.2.4. By End User
8.2.5.
By Country
8.3. Europe: Country Analysis
8.3.1.
Germany Genome
Editing Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Technique
8.3.1.2.2.
By Application
8.3.1.2.3.
By Delivery Method
8.3.1.2.4.
By End User
8.3.2.
United Kingdom
Genome Editing Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Technique
8.3.2.2.2.
By Application
8.3.2.2.3.
By Delivery Method
8.3.2.2.4.
By End User
8.3.3.
France Genome
Editing Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Technique
8.3.3.2.2.
By Application
8.3.3.2.3.
By Delivery Method
8.3.3.2.4.
By End User
8.3.4.
Italy Genome Editing
Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Technique
8.3.4.2.2.
By Application
8.3.4.2.3.
By Delivery Method
8.3.4.2.4.
By End User
8.3.5.
Spain Genome Editing
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Technique
8.3.5.2.2.
By Application
8.3.5.2.3.
By Delivery Method
8.3.5.2.4.
By End User
9.
Asia-Pacific Genome
Editing Market Outlook
9.1. Market Size & Forecast
9.1.1.
By Value
9.2. Market Share & Forecast
9.2.1.
By Technique
9.2.2.
By Application
9.2.3.
By Delivery Method
9.2.4.
By End User
9.2.5.
By Country
9.3. Asia-Pacific: Country Analysis
9.3.1.
China Genome Editing
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Technique
9.3.1.2.2.
By Application
9.3.1.2.3.
By Delivery Method
9.3.1.2.4.
By End User
9.3.2.
Japan Genome Editing
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Technique
9.3.2.2.2.
By Application
9.3.2.2.3.
By Delivery Method
9.3.2.2.4.
By End User
9.3.3.
India Genome Editing
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Technique
9.3.3.2.2.
By Application
9.3.3.2.3.
By Delivery Method
9.3.3.2.4.
By End User
9.3.4.
South Korea Genome
Editing Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Technique
9.3.4.2.2.
By Application
9.3.4.2.3.
By Delivery Method
9.3.4.2.4.
By End User
9.3.5.
Australia Genome
Editing Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Technique
9.3.5.2.2.
By Application
9.3.5.2.3.
By Delivery Method
9.3.5.2.4.
By End User
10.
South America Genome
Editing Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1. By Technique
10.2.2. By Application
10.2.3. By Delivery Method
10.2.4. By End
User
10.2.5. By Country
10.3.
South America:
Country Analysis
10.3.1. Brazil Genome Editing Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Technique
10.3.1.2.2.
By Application
10.3.1.2.3.
By Delivery Method
10.3.1.2.4.
By End User
10.3.2. Argentina Genome Editing Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Technique
10.3.2.2.2.
By Application
10.3.2.2.3.
By Delivery Method
10.3.2.2.4.
By End User
10.3.3. Colombia Genome Editing Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Technique
10.3.3.2.2.
By Application
10.3.3.2.3.
By Delivery Method
10.3.3.2.4.
By End User
11.
Middle East and
Africa Genome Editing Market Outlook
11.1.
Market Size &
Forecast
11.1.1. By Value
11.2.
Market Share &
Forecast
11.2.1. By Technique
11.2.2. By Application
11.2.3. By Delivery Method
11.2.4. By End
User
11.2.5. By Country
11.3.
MEA: Country
Analysis
11.3.1. South Africa Genome Editing
Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Technique
11.3.1.2.2.
By Application
11.3.1.2.3.
By Delivery Method
11.3.1.2.4.
By End User
11.3.2. Saudi Arabia Genome Editing
Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Technique
11.3.2.2.2.
By Application
11.3.2.2.3.
By Delivery Method
11.3.2.2.4.
By End User
11.3.3. UAE Genome Editing Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Technique
11.3.3.2.2.
By Application
11.3.3.2.3.
By Delivery Method
11.3.3.2.4.
By End User
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1.
Competition Outlook
14.2.
Players Profiled
(Leading Companies)
14.2.1. Thermo Fisher Scientific Inc.
14.2.2. Homology Medicines, Inc.
14.2.3. CRISPR Therapeutics AG
14.2.4. Pfizer Inc.
14.2.5. Editas Medicine Inc.
14.2.6. Intellia Therapeutics Inc.
14.2.7. Cellectis SA
14.2.8. Sangamo Therapeutics Inc.
14.2.9. Origene Technologies Inc.
14.2.10.
Merck & Co Inc.
14.2.11.
New England Biolabs
Inc.
14.2.12.
Lonza Group AG
14.2.13.
Danaher Corporation
(Integrated DNA Technologies Inc.)
14.2.14.
PerkinElmer Inc.
(Horizon Discovery Group Plc)
14.2.15.
Genscript Corp.
14.2.16.
Oxford Genetics Ltd.
14.2.17.
Bayer AG
14.2.18.
Arcturus
Therapeutics Inc
14.2.19.
Inscripta Inc.
14.2.20.
Beam therapeutics
Inc.
15.
Strategic Recommendations
16.
About Us & Disclaimer